FDA Sets Strong Warnings for Asthma Drug Labels


Reuters

May 15, 2006—The U.S. Food and Drug Administration said on Monday that product labels for three popular asthma medications have been updated to state that the drugs could increase the chance of severe asthma attacks that could result in death.

The warnings, first proposed last November, involve long-acting bronchodilator medicines Advair and Serevent, made by GlaxoSmithKline Plc, and Foradil from Novartis AG.

In a public health advisory issued on its Web site, the FDA said the inhaled drugs should only be used after other medicines,
such as inhlaed corticosteroids, fail to control asthma.

Advair News
Study Cites Increased Death Risk From Asthma Drugs
Washington Post
June 6, 2006
FDA Sets Strong Warnings for Asthma Drugs
Reuters
May 15, 2006
Death Risk Warning for Asthma Drugs
Fox News
March 8, 2006

Contact Us
Name
Phone
Email

About Our Lawyers

Greg Monforton and Partners has grown to a highly respected products liability law firm with offices conveniently located throughout Windsor and Essex County, together with affiliate relationships with law firms throughout Ontario, Canada and the United States.

We are committed to protecting the rights of individuals injured by defective products. The firm never represents insurance companies or product manufacturers. We only help people.